does pfizer have a glp-1 drug Pfizer's Push into GLP‑1 Drugs Signals New Era in Obesity Treatment — and a Pfizer Accelerates Obesity Pipeline with

REWIND, Researching Cardiovascular Events With a Weekly Incretin in Diabetes

4 , 5 As GLP-1 agonist medications are recommended to be used in conjunction with diet and exercise, addressing musculoskeletal concerns is essential for optimizing physical function and promoting sustainable health outcomes amidst the broader benefits and challenges associated with GLP-1 agonist use

Information provided by Blue Cross and Blue Shield of Texas is for informational and educational purposes only and is not a substitute for the independent medical judgment of a physician or other health care provider, nor is the information presented intended to replace or supersede any requirements set forth in your contract with BCBSTX

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation